These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31119504)

  • 1. Metformin in tuberculosis: beyond control of hyperglycemia.
    Oglesby W; Kara AM; Granados H; Cervantes JL
    Infection; 2019 Oct; 47(5):697-702. PubMed ID: 31119504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.
    Novita BD; Ali M; Pranoto A; Soediono EI; Mertaniasih NM
    Indian J Tuberc; 2019 Jan; 66(1):64-69. PubMed ID: 30797286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of combined tuberculosis and diabetes.
    van Crevel R; Koesoemadinata R; Hill PC; Harries AD
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1404-1410. PubMed ID: 30606312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients.
    Restrepo BI
    Tuberculosis (Edinb); 2016 Dec; 101S():S69-S72. PubMed ID: 27720378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.
    Degner NR; Wang JY; Golub JE; Karakousis PC
    Clin Infect Dis; 2018 Jan; 66(2):198-205. PubMed ID: 29325084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review.
    Yu X; Li L; Xia L; Feng X; Chen F; Cao S; Wei X
    BMC Infect Dis; 2019 Oct; 19(1):859. PubMed ID: 31623569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
    Heo E; Kim E; Jang EJ; Lee CH
    BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
    BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin: A review of its potential as enhancer for anti tuberculosis efficacy in diabetes mellitus-tuberculosis coinfection patients.
    Novita BD
    Indian J Tuberc; 2019 Apr; 66(2):294-298. PubMed ID: 31151499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment.
    Kumar NP; Moideen K; Viswanathan V; Shruthi BS; Sivakumar S; Menon PA; Kornfeld H; Babu S
    BMC Infect Dis; 2018 Jul; 18(1):345. PubMed ID: 30045688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.
    Lee YJ; Han SK; Park JH; Lee JK; Kim DK; Chung HS; Heo EY
    Korean J Intern Med; 2018 Sep; 33(5):933-940. PubMed ID: 29540054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
    Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
    BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis-Related Diabetes: Is It Reversible after Complete Treatment?
    Aftab H; Christensen DL; Ambreen A; Jamil M; Garred P; Petersen JH; Nielsen SD; Bygbjerg IC
    Am J Trop Med Hyg; 2017 Oct; 97(4):1099-1102. PubMed ID: 28820679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of metformin in diabetic patients with and without tuberculosis.
    Mary Rebecca Y; Sudha V; Bharathiraja T; Kannan T; Lavanya J; Hemanth Kumar AK
    Indian J Tuberc; 2023 Jan; 70(1):37-41. PubMed ID: 36740315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.
    Ma Y; Pang Y; Shu W; Liu YH; Ge QP; Du J; Li L; Gao WW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1259-1263. PubMed ID: 29679254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Hu M; Zheng C; Gao F
    Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients.
    Novita BD; Pranoto A; Wuryani ; Soediono EI; Mertaniasih NM
    Indian J Tuberc; 2018 Jul; 65(3):252-256. PubMed ID: 29933869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes.
    Inzucchi SE
    Diabetes Care; 2017 Aug; 40(8):1128-1132. PubMed ID: 28733378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
    Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
    Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.